ARIDIS PHARMACEUTICALS INC's ticker is ARDS and the CUSIP is 040334104. A total of 7 filers reported holding ARIDIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $274,000 | +242.5% | 74,559 | +558.1% | 0.00% | – |
Q3 2020 | $80,000 | +8.1% | 11,329 | +1.1% | 0.00% | – |
Q2 2020 | $74,000 | +23.3% | 11,205 | +7.7% | 0.00% | – |
Q1 2020 | $60,000 | +17.6% | 10,403 | -9.1% | 0.00% | – |
Q4 2019 | $51,000 | -70.2% | 11,446 | -55.2% | 0.00% | – |
Q3 2019 | $171,000 | +44.9% | 25,569 | +137.6% | 0.00% | – |
Q1 2019 | $118,000 | -11.9% | 10,763 | -11.1% | 0.00% | – |
Q4 2018 | $134,000 | -56.2% | 12,112 | -48.6% | 0.00% | – |
Q3 2018 | $306,000 | – | 23,585 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Steward Partners Investment Advisory, LLC | 1,000 | $13,000 | 0.00% |
Tower Research Capital LLC (TRC) | 625 | $8,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
UBS Group AG | 1,809 | $24,000 | 0.00% |
GOLDMAN SACHS GROUP INC | 28,348 | $370,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 23,585 | $306,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 300 | $4,000 | 0.00% |